{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:48:55Z","timestamp":1790243335599,"version":"4.1.0"},"reference-count":35,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.33090","type":"journal-article","created":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T16:35:47Z","timestamp":1636994147000},"page":"e2133090","source":"Crossref","is-referenced-by-count":127,"title":["Mortality Risk Among Patients With COVID-19 Prescribed Selective Serotonin Reuptake Inhibitor Antidepressants"],"prefix":"10.1001","volume":"4","author":[{"given":"Tomiko","family":"Oskotsky","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of California, San Francisco"},{"name":"Bakar Computational Health Sciences Institute, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Mari\u0107","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of California, San Francisco"},{"name":"Bakar Computational Health Sciences Institute, University of California, San Francisco"},{"name":"Graduate Program in Bioengineering, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Oskotsky","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of California, San Francisco"},{"name":"Bakar Computational Health Sciences Institute, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald J.","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Aghaeepour","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Stanford University School of Medicine, Stanford, California"},{"name":"Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, California"},{"name":"Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Sirota","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of California, San Francisco"},{"name":"Bakar Computational Health Sciences Institute, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Stevenson","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Stanford University School of Medicine, Stanford, California"},{"name":"Center for Academic Medicine, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,11,15]]},"reference":[{"issue":"22","key":"zoi210938r2","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1001\/jama.2020.22760","article-title":"Fluvoxamine vs placebo and clinical deterioration in outpatients with symptomatic COVID-19: a randomized clinical trial.","volume":"324","author":"Lenze","year":"2020","journal-title":"JAMA"},{"issue":"2","key":"zoi210938r3","doi-asserted-by":"publisher","first-page":"b050","DOI":"10.1093\/ofid\/ofab050","article-title":"Prospective cohort of fluvoxamine for early treatment of coronavirus disease 19.","volume":"8","author":"Seftel","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"zoi210938r4","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3390\/microorganisms9020339","article-title":"Fluoxetine can inhibit SARS-CoV-2 in vitro.","volume":"9","author":"Dechaumes","year":"2021","journal-title":"Microorganisms"},{"issue":"1","key":"zoi210938r5","doi-asserted-by":"publisher","first-page":"5890","DOI":"10.1038\/s41598-021-85049-0","article-title":"The serotonin reuptake inhibitor fluoxetine inhibits SARS-CoV-2 in human lung tissue.","volume":"11","author":"Zimniak","year":"2021","journal-title":"Sci Rep"},{"key":"zoi210938r6","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111437","article-title":"Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection.","volume":"138","author":"Creeden","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"zoi210938r7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cytogfr.2020.06.001","article-title":"SARS-CoV-2 infection: the role of cytokines in COVID-19 disease.","volume":"54","author":"Costela-Ruiz","year":"2020","journal-title":"Cytokine Growth Factor Rev"},{"issue":"4","key":"zoi210938r8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.4088\/PCC.v05n0402","article-title":"Trends in prescribing of selective serotonin reuptake inhibitors and other newer antidepressant agents in adult primary care.","volume":"5","author":"Pirraglia","year":"2003","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"zoi210938r9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fpsyt.2020.00035","article-title":"National prescription patterns of antidepressants in the treatment of adults with major depression in the US between 1996 and 2015: a population representative survey based analysis.","volume":"11","author":"Luo","year":"2020","journal-title":"Front Psychiatry"},{"issue":"7","key":"zoi210938r10","doi-asserted-by":"publisher","first-page":"839","DOI":"10.4088\/JCP.10r06218blu","article-title":"The pharmacologic treatment of anxiety disorders: a review of progress.","volume":"71","author":"Ravindran","year":"2010","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"zoi210938r11","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1038\/npp.2011.132","article-title":"The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis.","volume":"36","author":"Hannestad","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"zoi210938r12","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/art.27304","article-title":"Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors.","volume":"62","author":"Sacre","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"8","key":"zoi210938r13","article-title":"Pharmacological inhibition of acid sphingomyelinase prevents uptake of SARS-CoV-2 by epithelial cells.","volume":"1","author":"Carpinteiro","year":"2020","journal-title":"Cell Rep Med"},{"key":"zoi210938r14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100701","article-title":"Inhibition of acid sphingomyelinase by ambroxol prevents SARS-CoV-2 entry into epithelial cells.","volume":"296","author":"Carpinteiro","year":"2021","journal-title":"J Biol Chem"},{"issue":"9","key":"zoi210938r15","doi-asserted-by":"publisher","first-page":"4794","DOI":"10.3390\/ijms22094794","article-title":"Metabolic signatures associated with severity in hospitalized COVID-19 patients.","volume":"22","author":"Mar\u00edn-Corral","year":"2021","journal-title":"Int J Mol Sci"},{"key":"zoi210938r16","article-title":"Association between FIASMAs and reduced risk of intubation or death in individuals hospitalized for severe COVID-19: an observational multicenter study.","author":"Hoertel","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"zoi210938r19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S2215-0366(20)30462-4","article-title":"Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62?354 COVID-19 cases in the USA.","volume":"8","author":"Taquet","year":"2021","journal-title":"Lancet Psychiatry"},{"issue":"6","key":"zoi210938r20","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/acps.v143.6","article-title":"Mental disorders, psychopharmacological treatments, and mortality in 2150 COVID-19 Spanish inpatients.","volume":"143","author":"Diez-Quevedo","year":"2021","journal-title":"Acta Psychiatr Scand"},{"issue":"9596","key":"zoi210938r22","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"issue":"24","key":"zoi210938r24","doi-asserted-by":"publisher","first-page":"4306","DOI":"10.1002\/sim.v33.24","article-title":"The use of bootstrapping when using propensity-score matching without replacement: a simulation study.","volume":"33","author":"Austin","year":"2014","journal-title":"Stat Med"},{"key":"zoi210938r25","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jad.2015.03.021","article-title":"Dose equivalents of antidepressants: evidence-based recommendations from randomized controlled trials.","volume":"180","author":"Hayasaka","year":"2015","journal-title":"J Affect Disord"},{"issue":"7","key":"zoi210938r26","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S2215-0366(19)30217-2","article-title":"Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis.","volume":"6","author":"Furukawa","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"zoi210938r28","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110140","article-title":"The possible immunoregulatory and anti-inflammatory effects of selective serotonin reuptake inhibitors in coronavirus disease patients.","volume":"144","author":"Hamed","year":"2020","journal-title":"Med Hypotheses"},{"issue":"0","key":"zoi210938r29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jocn.2021.03.010","article-title":"Drug repurposing of selective serotonin reuptake inhibitors: could these drugs help fight COVID-19 and save lives?","volume":"88","author":"Pashaei","year":"2021","journal-title":"J Clin Neurosci"},{"issue":"1","key":"zoi210938r30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.coph.2011.02.004","article-title":"5-HT and the immune system.","volume":"11","author":"Ahern","year":"2011","journal-title":"Curr Opin Pharmacol"},{"issue":"5","key":"zoi210938r31","first-page":"4195","article-title":"Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis.","volume":"55","author":"K\u00f6hler","year":"2018","journal-title":"Mol Neurobiol"},{"issue":"1","key":"zoi210938r32","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/j.1749-6632.1995.tb32372.x","article-title":"Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine.","volume":"762","author":"Sluzewska","year":"1995","journal-title":"Ann N Y Acad Sci"},{"key":"zoi210938r33","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ejphar.2014.01.064","article-title":"Interaction of new antidepressants with sigma-1 receptor chaperones and their potentiation of neurite outgrowth in PC12 cells.","volume":"727","author":"Ishima","year":"2014","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"zoi210938r34","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0924-8579(99)00157-0","article-title":"Inhibition of HIV replication by neuroleptic agents and their potential use in HIV infected patients with AIDS related dementia.","volume":"14","author":"Kristiansen","year":"2000","journal-title":"Int J Antimicrob Agents"},{"issue":"9","key":"zoi210938r35","doi-asserted-by":"publisher","first-page":"4838","DOI":"10.1128\/AAC.00983-12","article-title":"Fluoxetine is a potent inhibitor of coxsackievirus replication.","volume":"56","author":"Zuo","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"zoi210938r1","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-021-01021-4","article-title":"Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study.","volume-title":"Mol Psychiatry","author":"Hoertel"},{"key":"zoi210938r17","doi-asserted-by":"crossref","unstructured":"Hoertel? N, S\u00e1nchez-Rico? M, Gulbins? E, . Association between psychotropic medications functionally inhibiting acid sphingomyelinase and reduced risk of intubation or death among individuals with mental disorder and severe COVID-19: an observational study.? medRxiv. Preprint posted online February 20, 2021. doi:10.1101\/2021.02.18.21251997","DOI":"10.1101\/2021.02.18.21251997"},{"key":"zoi210938r18","doi-asserted-by":"crossref","unstructured":"Wang QQ, Xu R, Volkow ND. Increased risk of COVID-19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States. World Psychiatry. Published online October 7, 2020. Accessed September 3, 2021. https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/wps.20806","DOI":"10.1002\/wps.20806"},{"key":"zoi210938r21","doi-asserted-by":"crossref","unstructured":"G\u00fcnster? C, Busse? R, Spoden? M, . 6-Month follow up of 8679 hospitalized COVID-19 patients in Germany: a nationwide cohort study.? medRxiv. Preprint posted online April 24, 2012. doi:10.1101\/2021.04.24.21256029","DOI":"10.1101\/2021.04.24.21256029"},{"key":"zoi210938r23","unstructured":"ICD-10 Version:2019. Updated April 16, 2020. Accessed August 9, 2021. https:\/\/icd.who.int\/browse10\/2019\/en#\/U07.1"},{"key":"zoi210938r27","unstructured":"CDC\/National Center for Health Statistics. Antidepressant use among adults: United States, 2015-2018. September 8, 2020. Accessed September 3, 2021. https:\/\/www.cdc.gov\/nchs\/products\/databriefs\/db377.htm"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2786136\/oskotsky_2021_oi_210938_1636051230.14579.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T16:35:57Z","timestamp":1636994157000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2786136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,15]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.33090","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,15]]}}}